Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medacta GroupMEDGF 91 Interest Coverage is 0 (At Loss) as of Dec. 2025. GuruFocus rates MEDGF with a GF Score™ of 91/100 and a GF Value™ of $100.71. The stock has 2 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Medacta Group ranks better than 50.21% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Medacta Group's
Operating Income
for the
six
months ended in Dec. 2025 was $59.7 Mil. Medacta Group's Interest Expense for the
six
months ended in Dec. 2025 was $7.6 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Medacta Group's Interest Coverage or its related term are showing as below:
MEDGF'
s Interest Coverage Range Over the Past 10 Years
Min: 7.93 Med: 16.57 Max: 42.62
Current: 16.24
MEDGF's Interest Coverage is ranked better than 50.21% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 16.08
vs MEDGF: 16.24
Medacta Group (OTCPK:MEDGF) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Medacta Group Interest Coverage Related Terms
Medacta Group Interest Coverage Historical Data
* Premium members only.
The historical data trend for Medacta Group's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
MEDGF vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Medacta Group's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medacta Group Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Medacta Group's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Medacta Group (MEDGF) has a Interest Coverage of 0 (At Loss) as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Medacta Group and its competitors. Over the past decade, Medacta Group's Interest Coverage has ranged from 7.93 to 42.62. According to the industry distribution chart, Medacta Group ranks #232 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 49.8%.
Is Medacta Group's Interest Coverage too high?
Medacta Group's current Interest Coverage is 0 (At Loss). Over the past 10 years, this metric has ranged from a low of 7.93 to a high of 42.62. Based on the distribution chart, Medacta Group ranks #232 out of 466 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medacta Group has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Medacta Group's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medacta Group ranks #232 out of 466 companies for Interest Coverage. This puts Medacta Group in the upper half of its industry. The industry median Interest Coverage is 16.08. Historically, Medacta Group's own Interest Coverage has ranged from 7.93 to 42.62 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.08, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Medacta Group and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medacta Group's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medacta Group stock overvalued right now?
Medacta Group (MEDGF) has a current Interest Coverage of 0 (At Loss). The stock's GF Value™ is $100.71, compared to a current price of $83.91 — trading 16.7% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Medacta Group's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Medacta Group (MEDGF), the current Interest Coverage is 0 (At Loss) as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medacta Group (MEDGF) Overvalued in 2026?
Based on GuruFocus' analysis, Medacta Group stock appears to be undervalued.
The current stock price of $83.91 is trading 16.7% below its estimated GF Value™ of $100.71.
Key valuation signals for MEDGF:
Interest Coverage: 0 (At Loss)
GF Value™: $100.71 vs. price of $83.91 (16.7% below fair value)
No single metric tells the full story. See the MEDGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medacta Group SA is involved in developing, manufacturing, and distributing orthopedic and neurosurgical medical devices. It specializes in the design, production, and distribution of personalized and sustainable solutions for joint replacement, sports medicine, and spine surgery. Medacta's product portfolio includes hip, knee, shoulder, and spine replacement solutions, along with a comprehensive range of sports medicine. Its products and surgical techniques are supported by an extensive program of surgeon education and engagement initiatives, enabling its offerings to be effective for the patient and surgeon. Geographically, the company derives maximum revenue from EMEA (which includes Europe, Middle East and Africa), followed by North America, Asia-Pacific, and the Latin America markets.
91GF Score
Get the complete analysis for MEDGF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDGF has been successfully added to your 
